Alnylam Pharmaceuticals, Inc. (ALNY)
USD 222.68
(-5.54%)
USD 222.68
(-5.54%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -258.24 Million USD | 74.5% |
| 2022 | -926.55 Million USD | -26.13% |
| 2021 | -661.55 Million USD | 8.04% |
| 2020 | -736.33 Million USD | 17.92% |
| 2019 | -868.07 Million USD | -12.47% |
| 2018 | -754.23 Million USD | -67.02% |
| 2017 | -488.19 Million USD | -17.78% |
| 2016 | -409.45 Million USD | -43.44% |
| 2015 | -276.95 Million USD | -909.83% |
| 2014 | -172.28 Million USD | 139.33% |
| 2013 | -82.71 Million USD | -498.08% |
| 2012 | -51.71 Million USD | 71.37% |
| 2011 | -49.69 Million USD | -7.56% |
| 2010 | -38.06 Million USD | -5.96% |
| 2009 | -41.01 Million USD | -109.75% |
| 2008 | -18.93 Million USD | 74.43% |
| 2007 | -75.05 Million USD | -150.67% |
| 2006 | -35.68 Million USD | 12.15% |
| 2005 | -38.82 Million USD | -36.31% |
| 2004 | -29.54 Million USD | -97.6% |
| 2003 | -19.61 Million USD | -257.69% |
| 2002 | -4.18 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | -76.9 Million USD | -262.57% |
| 2024 Q1 | -29.91 Million USD | 84.04% |
| 2024 Q2 | 63.61 Million USD | 350.35% |
| 2023 Q4 | -102.92 Million USD | -156.66% |
| 2023 Q3 | 181.63 Million USD | 174.39% |
| 2023 Q2 | -244.17 Million USD | -70.27% |
| 2023 Q1 | -143.4 Million USD | 19.03% |
| 2023 FY | - USD | 74.5% |
| 2022 Q4 | -177.1 Million USD | 24.54% |
| 2022 Q1 | -142.59 Million USD | 36.2% |
| 2022 Q2 | -168.5 Million USD | -18.17% |
| 2022 FY | - USD | -26.13% |
| 2022 Q3 | -234.68 Million USD | -39.28% |
| 2021 Q2 | -123.73 Million USD | 28.34% |
| 2021 Q3 | -140.74 Million USD | -13.75% |
| 2021 FY | - USD | 8.04% |
| 2021 Q4 | -223.48 Million USD | -58.79% |
| 2021 Q1 | -172.66 Million USD | 19.72% |
| 2020 Q2 | -132.87 Million USD | 31.21% |
| 2020 Q4 | -215.08 Million USD | -4.94% |
| 2020 Q3 | -204.95 Million USD | -54.24% |
| 2020 FY | - USD | 17.92% |
| 2020 Q1 | -193.15 Million USD | 35.2% |
| 2019 Q4 | -298.07 Million USD | -50.05% |
| 2019 FY | - USD | -12.47% |
| 2019 Q2 | -236.27 Million USD | -25.15% |
| 2019 Q1 | -188.78 Million USD | 14.33% |
| 2019 Q3 | -198.64 Million USD | 15.92% |
| 2018 Q3 | -251.31 Million USD | -19.29% |
| 2018 Q4 | -220.35 Million USD | 12.32% |
| 2018 FY | - USD | -67.02% |
| 2018 Q1 | -147.4 Million USD | -0.07% |
| 2018 Q2 | -210.67 Million USD | -42.93% |
| 2017 FY | - USD | -17.78% |
| 2017 Q2 | -117.4 Million USD | -13.43% |
| 2017 Q4 | -147.3 Million USD | -20.53% |
| 2017 Q3 | -122.21 Million USD | -4.09% |
| 2017 Q1 | -103.51 Million USD | 10.33% |
| 2016 Q4 | -115.43 Million USD | -11.88% |
| 2016 Q2 | -88.43 Million USD | 19.62% |
| 2016 FY | - USD | -43.44% |
| 2016 Q1 | -110.02 Million USD | -18.93% |
| 2016 Q3 | -103.17 Million USD | -16.66% |
| 2015 Q2 | -72.94 Million USD | -39.68% |
| 2015 Q4 | -92.51 Million USD | -26.62% |
| 2015 Q3 | -73.06 Million USD | -0.16% |
| 2015 FY | - USD | -909.83% |
| 2015 Q1 | -52.22 Million USD | -14.24% |
| 2014 Q2 | -52.78 Million USD | -129.28% |
| 2014 Q3 | -45.19 Million USD | 14.37% |
| 2014 Q4 | -45.71 Million USD | -1.13% |
| 2014 FY | - USD | 139.33% |
| 2014 Q1 | 180.24 Million USD | 709.11% |
| 2013 Q3 | -29.47 Million USD | -58.43% |
| 2013 Q1 | -9.8 Million USD | -138.35% |
| 2013 Q2 | -18.6 Million USD | -89.73% |
| 2013 FY | - USD | -498.08% |
| 2013 Q4 | -29.59 Million USD | -0.41% |
| 2012 Q4 | 25.56 Million USD | 240.91% |
| 2012 Q1 | -8.96 Million USD | 27.43% |
| 2012 Q3 | -18.14 Million USD | -50.62% |
| 2012 FY | - USD | 71.37% |
| 2012 Q2 | -12.04 Million USD | -34.4% |
| 2011 Q4 | -12.35 Million USD | -4.3% |
| 2011 Q2 | -13.1 Million USD | 16.85% |
| 2011 Q1 | -15.75 Million USD | 3.93% |
| 2011 FY | - USD | -7.56% |
| 2011 Q3 | -11.84 Million USD | 9.62% |
| 2010 Q3 | -7.48 Million USD | 35.88% |
| 2010 FY | - USD | -5.96% |
| 2010 Q1 | -11.29 Million USD | -49.05% |
| 2010 Q2 | -11.66 Million USD | -3.31% |
| 2010 Q4 | -16.4 Million USD | -119.21% |
| 2009 FY | - USD | -109.75% |
| 2009 Q4 | -7.57 Million USD | 12.28% |
| 2009 Q3 | -8.63 Million USD | 56.43% |
| 2009 Q2 | -19.82 Million USD | -254.05% |
| 2009 Q1 | -5.6 Million USD | -102.39% |
| 2008 Q1 | -3.08 Million USD | -56.28% |
| 2008 Q4 | -2.76 Million USD | -4754.39% |
| 2008 Q3 | -57 Thousand USD | 99.49% |
| 2008 FY | - USD | 74.43% |
| 2008 Q2 | -11.07 Million USD | -258.58% |
| 2007 Q2 | -13.97 Million USD | 38.56% |
| 2007 Q4 | -1.97 Million USD | 96.06% |
| 2007 FY | - USD | -150.67% |
| 2007 Q1 | -22.74 Million USD | -154.72% |
| 2007 Q3 | -50.12 Million USD | -258.65% |
| 2006 Q3 | -7.52 Million USD | 25.14% |
| 2006 Q4 | -8.92 Million USD | -18.64% |
| 2006 Q1 | -8.92 Million USD | 36.5% |
| 2006 FY | - USD | 12.15% |
| 2006 Q2 | -10.05 Million USD | -12.66% |
| 2005 Q1 | -6.04 Million USD | -31.94% |
| 2005 Q4 | -14.05 Million USD | -41.53% |
| 2005 FY | - USD | -36.31% |
| 2005 Q3 | -9.92 Million USD | 3.61% |
| 2005 Q2 | -10.3 Million USD | -70.32% |
| 2004 Q1 | -12.74 Million USD | 38.09% |
| 2004 Q2 | -6.56 Million USD | 48.49% |
| 2004 FY | - USD | -97.6% |
| 2004 Q4 | -4.58 Million USD | 19.55% |
| 2004 Q3 | -5.69 Million USD | 13.18% |
| 2003 FY | - USD | -257.69% |
| 2003 Q4 | -20.58 Million USD | -46872.73% |
| 2003 Q2 | -1.78 Million USD | -40.92% |
| 2003 Q3 | 44 Thousand USD | 102.47% |
| 2003 Q1 | -1.26 Million USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AbCellera Biologics Inc. | -192.15 Million USD | -34.39% |
| Alkermes plc | 495.04 Million USD | 152.165% |
| Agenus Inc. | -145.92 Million USD | -76.97% |
| Aptorum Group Limited | -9.59 Million USD | -2590.302% |
| Ardelyx, Inc. | -55.35 Million USD | -366.528% |
| Dyadic International, Inc. | -8.22 Million USD | -3037.912% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | -88642.955% |
| Lantern Pharma Inc. | -15.78 Million USD | -1535.821% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | -1196.891% |
| Novavax, Inc. | -487.39 Million USD | 47.015% |
| Janux Therapeutics, Inc. | -71.02 Million USD | -263.598% |
| Pyxis Oncology, Inc. | -78.49 Million USD | -229.0% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | -1336.797% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | -2490.71% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | -350.088% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | 32.036% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -971.015% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | 48917.013% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | -64.281% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | -245.175% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -1181.026% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | -988.022% |
| Clearside Biomedical, Inc. | -23.05 Million USD | -1019.967% |
| C4 Therapeutics, Inc. | -122.1 Million USD | -111.495% |
| AlloVir, Inc. | -190.14 Million USD | -35.812% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | -47.002% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -782.637% |
| Bicycle Therapeutics plc | -183.4 Million USD | -40.808% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | -56.112% |
| ChromaDex Corporation | -3.89 Million USD | -6531.793% |
| Chimerix, Inc. | -92.97 Million USD | -177.757% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | -481.146% |
| Caribou Biosciences, Inc. | -112.53 Million USD | -129.479% |
| CRISPR Therapeutics AG | -202.7 Million USD | -27.4% |
| Precision BioSciences, Inc. | -32.04 Million USD | -705.948% |
| Fate Therapeutics, Inc. | -172.22 Million USD | -49.941% |
| Fortress Biotech, Inc. | -133.64 Million USD | -93.233% |
| Fortress Biotech, Inc. | -133.64 Million USD | -93.233% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | -233.892% |
| ImmuCell Corporation | -2.5 Million USD | -10212.862% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | -98.006% |
| Immix Biopharma, Inc. | -16.13 Million USD | -1500.444% |
| Incyte Corporation | 919.42 Million USD | 128.087% |
| Innoviva, Inc. | 248.96 Million USD | 203.728% |
| IO Biotech, Inc. | -91.22 Million USD | -183.073% |
| Jaguar Health, Inc. | -33.13 Million USD | -679.457% |
| Keros Therapeutics, Inc. | -152.17 Million USD | -69.698% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | 353.858% |
| ContextLogic Inc. | -324 Million USD | 20.296% |
| MiMedx Group, Inc. | 40.51 Million USD | 737.367% |
| MEI Pharma, Inc. | 26.38 Million USD | 1078.931% |
| NextCure, Inc. | -59.03 Million USD | -337.409% |
| Onconetix, Inc. | -36.7 Million USD | -603.528% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | 11654.452% |
| Opthea Limited | -200.01 Million USD | -29.109% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -9285.226% |
| Vaxcyte, Inc. | -464.88 Million USD | 44.45% |
| PDS Biotechnology Corporation | -40.08 Million USD | -544.236% |
| Precigen, Inc. | -89.22 Million USD | -189.425% |
| Pharming Group N.V. | 9.87 Million USD | 2714.579% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | -62.366% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | -1034.531% |
| PureTech Health plc | -11.62 Million USD | -2121.054% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | -1420.77% |
| Avidity Biosciences, Inc. | -233.49 Million USD | -10.598% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -971.015% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | -195.38% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | -791.627% |
| Acelyrin, Inc. | -381.52 Million USD | 32.313% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | -2004123.552% |
| Summit Therapeutics Inc. | 1 Million USD | 25898.402% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | -673.504% |
| Senti Biosciences, Inc. | -61.33 Million USD | -321.028% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | -129.949% |
| Elevation Oncology, Inc. | -41.46 Million USD | -522.765% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | -735.626% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | -4122.023% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | -80349.221% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | -695.742% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | -2975.774% |
| Wave Life Sciences Ltd. | -58.79 Million USD | -339.262% |
| Seer, Inc. | -97.88 Million USD | -163.822% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | -315.2% |
| Aadi Bioscience, Inc. | -65.36 Million USD | -295.077% |
| ESSA Pharma Inc. | -26.45 Million USD | -876.144% |
| GlycoMimetics, Inc. | -39.12 Million USD | -560.094% |
| GT Biopharma, Inc. | 5.97 Million USD | 4419.15% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | -24.94% |
| Akebia Therapeutics, Inc. | -6.86 Million USD | -3660.076% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 397.473% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -355.02% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | -404.192% |
| Alzamend Neuro, Inc. | -9.88 Million USD | -2511.96% |
| Sorrento Therapeutics, Inc. | -539.92 Million USD | 52.171% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | -3651.336% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | -451.069% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | -9.137% |
| Aptose Biosciences Inc. | -52.26 Million USD | -394.073% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | -139.682% |
| Soligenix, Inc. | -7.85 Million USD | -3188.513% |
| Century Therapeutics, Inc. | -121.2 Million USD | -113.057% |
| Kura Oncology, Inc. | -164.95 Million USD | -56.553% |
| TScan Therapeutics, Inc. | -80.09 Million USD | -222.408% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | -2460.401% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | -26863.713% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | -5893.084% |
| Autolus Therapeutics plc | -156.77 Million USD | -64.727% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -205.045% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | -274.258% |
| Eterna Therapeutics Inc. | -19.93 Million USD | -1195.485% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | -36.439% |
| GRI Bio, Inc. | -10.89 Million USD | -2269.627% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -5618.74% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | -110.799% |
| IGM Biosciences, Inc. | -253.35 Million USD | -1.928% |
| INmune Bio, Inc. | - USD | Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | -148.807% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -577.21% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -1584.454% |
| Entero Therapeutics, Inc. | -15.74 Million USD | -1540.336% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | -354.291% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | -141.116% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | 2.915% |
| Coherus BioSciences, Inc. | -193.93 Million USD | -33.156% |
| Verastem, Inc. | -83.16 Million USD | -210.514% |
| Abeona Therapeutics Inc. | -50.57 Million USD | -410.642% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | -63.209% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | -126.351% |
| Histogen Inc. | -10.5 Million USD | -2358.745% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | -1708.454% |
| Surrozen, Inc. | -41.13 Million USD | -527.852% |
| Organovo Holdings, Inc. | -14.8 Million USD | -1644.171% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 8052547.771% |
| Ovid Therapeutics Inc. | -58.71 Million USD | -339.836% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -403.455% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | -1098.951% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | -2997.168% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | -55.505% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | -424.259% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | -968.617% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | -1615.319% |
| Apollomics, Inc. | -171.74 Million USD | -50.362% |
| Amarin Corporation plc | -50.9 Million USD | -407.336% |
| Mesoblast Limited | -61.33 Million USD | -321.063% |
| Turnstone Biologics Corp. | -56.23 Million USD | -359.228% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | -80.335% |
| Synaptogenix, Inc. | -8.3 Million USD | -3008.538% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | -1583.565% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | -309.602% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -5289.624% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | 60290.799% |
| Exelixis, Inc. | 196.6 Million USD | 231.353% |
| Better Therapeutics, Inc. | -38.26 Million USD | -574.931% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | -82.621% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | 47.852% |
| NLS Pharmaceutics AG | -11.79 Million USD | -2089.298% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | 104560.067% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | -775.219% |
| Gritstone bio, Inc. | -126.86 Million USD | -103.56% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -297.387% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -6356.137% |
| Avid Bioservices, Inc. | -11.48 Million USD | -2149.299% |
| Insmed Incorporated | -654.73 Million USD | 60.558% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | -11378.856% |
| MediWound Ltd. | -4.89 Million USD | -5177.785% |
| OmniAb, Inc. | -49.73 Million USD | -419.278% |
| Alector, Inc. | -142.89 Million USD | -80.725% |
| Seres Therapeutics, Inc. | -85.43 Million USD | -202.271% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -395.21% |
| Zai Lab Limited | -366.57 Million USD | 29.552% |
| Revance Therapeutics, Inc. | -290.63 Million USD | 11.146% |
| Aura Biosciences, Inc. | -83.69 Million USD | -208.548% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | -14.647% |
| Immunic, Inc. | -99.11 Million USD | -160.556% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | -96.128% |
| Veracyte, Inc. | -49.4 Million USD | -422.662% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | -3555.783% |
| FibroGen, Inc. | -261.4 Million USD | 1.21% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -2217.943% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -3588.472% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | -1279.729% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 117.817% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | -915.821% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | 747.385% |
| TG Therapeutics, Inc. | 26.1 Million USD | 1089.433% |
| Galecto, Inc. | -37.51 Million USD | -588.297% |
| Calithera Biosciences, Inc. | -38.26 Million USD | -574.878% |
| Fortrea Holdings Inc. | 167.3 Million USD | 254.359% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | -92.316% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | -812.161% |
| XBiotech Inc. | -35.76 Million USD | -622.032% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -297.387% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | -295.773% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | -147.228% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -905.929% |
| Theravance Biopharma, Inc. | -40.86 Million USD | -531.908% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | 49.997% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | -360.974% |
| Vaxxinity, Inc. | -56.05 Thousand USD | -460626.838% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | -121.981% |
| Gain Therapeutics, Inc. | -22.16 Million USD | -1064.85% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | -9.86% |
| NexImmune, Inc. | -28.16 Million USD | -816.808% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | -4573.6% |
| Marker Therapeutics, Inc. | -11.79 Million USD | -2089.926% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 105.549% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | -917.021% |
| Scopus BioPharma Inc. | -11.71 Million USD | -2104.719% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | -105.205% |
| Ainos, Inc. | -8.77 Million USD | -2843.567% |
| Pluri Inc. | -20.22 Million USD | -1176.845% |
| Prothena Corporation plc | -190.1 Million USD | -35.84% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | -101.44% |
| Celularity Inc. | -183.94 Million USD | -40.39% |
| Rallybio Corporation | -72.37 Million USD | -256.821% |
| Cue Biopharma, Inc. | -46.05 Million USD | -460.762% |
| MeiraGTx Holdings plc | -57.05 Million USD | -352.643% |
| Omeros Corporation | -163.61 Million USD | -57.84% |
| Humacyte, Inc. | -96.45 Million USD | -167.725% |
| Immunocore Holdings plc | -59.64 Million USD | -332.936% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | -1233.068% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | -959.889% |
| Blueprint Medicines Corporation | -474.61 Million USD | 45.589% |
| CalciMedica, Inc. | -34.18 Million USD | -655.337% |
| Cabaletta Bio, Inc. | -73.23 Million USD | -252.626% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | -105.775% |
| Scholar Rock Holding Corporation | -168.45 Million USD | -53.304% |
| Sana Biotechnology, Inc. | -252.39 Million USD | -2.319% |
| Pulmatrix, Inc. | -12.64 Million USD | -1942.084% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | -683.359% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | -191.908% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | 48.996% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | -155.142% |
| Cytokinetics, Incorporated | -456.68 Million USD | 43.453% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | -673.805% |
| Nutriband Inc. | -5.12 Million USD | -4942.039% |
| Protara Therapeutics, Inc. | -43.27 Million USD | -496.788% |
| Vor Biopharma Inc. | -114.37 Million USD | -125.793% |
| Roivant Sciences Ltd. | -996.51 Million USD | 74.085% |
| Evogene Ltd. | -23.2 Million USD | -1012.92% |
| ProKidney Corp. | -147.66 Million USD | -74.879% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -300.158% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | -168521.408% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | 54.331% |
| CorMedix Inc. | -48.88 Million USD | -428.242% |
| BioLineRx Ltd. | -57.06 Million USD | -352.572% |
| Tango Therapeutics, Inc. | -111.75 Million USD | -131.072% |
| Galectin Therapeutics Inc. | -202 Thousand USD | -127742.574% |
| Atai Life Sciences N.V. | -36.31 Million USD | -611.195% |
| Renovaro Biosciences Inc. | -79.51 Million USD | -224.763% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | -217.59% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | 6.265% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -740.085% |
| MediciNova, Inc. | -9.87 Million USD | -2513.793% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | -105.05% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -16776.345% |
| GeoVax Labs, Inc. | -26.66 Million USD | -868.331% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | -14.779% |
| Biomea Fusion, Inc. | -124.62 Million USD | -107.224% |
| PTC Therapeutics, Inc. | -330.34 Million USD | 21.825% |
| Mereo BioPharma Group plc | -26.05 Million USD | -891.104% |
| Cullinan Oncology, Inc. | -190.33 Million USD | -35.675% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | -12.307% |
| Absci Corporation | -95.45 Million USD | -170.532% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -760.09% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | -141.082% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | -10.608% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | -1029.915% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | -24.253% |
| Allakos Inc. | -189.91 Million USD | -35.978% |
| Imunon, Inc. | -19.87 Million USD | -1199.116% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | -138.029% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | 338.398% |
| BioAtla, Inc. | -122.24 Million USD | -111.256% |
| NLS Pharmaceutics AG | -11.79 Million USD | -2089.298% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | -1538.487% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | 14.003% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | -523.066% |
| XOMA Corporation | -39.36 Million USD | -556.069% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | -160.183% |
| Cara Therapeutics, Inc. | -117.65 Million USD | -119.5% |
| aTyr Pharma, Inc. | -52.17 Million USD | -394.925% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | -208.11% |
| Akero Therapeutics, Inc. | -148.63 Million USD | -73.747% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | -10.094% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | -1791.467% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | -3111.047% |
| Akari Therapeutics, Plc | -16.8 Million USD | -1436.972% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 136948.855% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | 157.14% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -3942.216% |
| UroGen Pharma Ltd. | -63.83 Million USD | -304.571% |
| Sutro Biopharma, Inc. | -67.91 Million USD | -280.243% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -3455.577% |
| Orgenesis Inc. | -60.71 Million USD | -325.314% |
| Entera Bio Ltd. | -8.8 Million USD | -2833.235% |
| GH Research PLC | -41.15 Million USD | -527.517% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | -911.96% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | -214.037% |
| Xencor, Inc. | -125.87 Million USD | -105.159% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | -18002.619% |
| Replimune Group, Inc. | -230.19 Million USD | -12.183% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | -1181.114% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | -2260.099% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -3942.216% |
| Portage Biotech Inc. | -18.19 Million USD | -1318.99% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -16776.345% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | -146.923% |
| OncoCyte Corporation | -23.12 Million USD | -1016.819% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -2185.254% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -2154.042% |
| Purple Biotech Ltd. | -22.22 Million USD | -1061.944% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | -3928.736% |
| scPharmaceuticals Inc. | -46.06 Million USD | -460.652% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | -1350.009% |
| HilleVax, Inc. | -132.46 Million USD | -94.95% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | -2328.684% |
| Tharimmune, Inc. | -9.3 Million USD | -2676.023% |
| Genprex, Inc. | -31.06 Million USD | -731.414% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | -37.71% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | -723.633% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | -33701.309% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | 171229.99% |
| OKYO Pharma Limited | -15.74 Thousand USD | -1639961.807% |
| Savara Inc. | -59.13 Million USD | -336.714% |
| Curis, Inc. | -45.13 Million USD | -472.104% |
| Daré Bioscience, Inc. | -30.7 Million USD | -741.138% |
| Carmell Therapeutics Corporation | -15.19 Million USD | -1599.951% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | -3504.215% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | -865.968% |
| BeiGene, Ltd. | -1.12 Billion USD | 77.037% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | -1484.19% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | 40.025% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | -185.856% |
| Erasca, Inc. | -121.31 Million USD | -112.878% |
| bluebird bio, Inc. | -167.16 Million USD | -54.487% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -5640.298% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | 183.228% |
| DBV Technologies S.A. | -85.98 Million USD | -200.344% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -5640.298% |
| Moderna, Inc. | -3.28 Billion USD | 92.134% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -506.074% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | -4472.273% |
| Molecular Templates, Inc. | 1.43 Million USD | 18158.881% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | -331.468% |
| Travere Therapeutics, Inc. | -326.24 Million USD | 20.844% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | -88.375% |
| Spruce Biosciences, Inc. | -47.36 Million USD | -445.205% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | -85.74% |
| Cogent Biosciences, Inc. | -205.86 Million USD | -25.445% |
| MacroGenics, Inc. | 2.01 Million USD | 12903.272% |
| RenovoRx, Inc. | -11.39 Million USD | -2167.27% |
| Adicet Bio, Inc. | -136.53 Million USD | -89.14% |
| Prime Medicine, Inc. | -193.75 Million USD | -33.28% |
| Aditxt, Inc. | -25.45 Million USD | -914.386% |
| Adagene Inc. | -14.95 Million USD | -1627.281% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -3432.675% |
| Quantum-Si incorporated | -91.8 Million USD | -181.297% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | 136.249% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | 304.217% |
| SciSparc Ltd. | -5.28 Million USD | -4789.095% |
| Vericel Corporation | 2.86 Million USD | 9116.83% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -271139.812% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | -1090.526% |
| Generation Bio Co. | -133.3 Million USD | -93.73% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -211.023% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | -200.201% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | -13.546% |
| Invivyd, Inc. | -196.61 Million USD | -31.344% |
| Relay Therapeutics, Inc. | -374.15 Million USD | 30.98% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | -2684.341% |
| Spero Therapeutics, Inc. | 27.15 Million USD | 1051.027% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -2410.86% |
| 2seventy bio, Inc. | -206.41 Million USD | -25.106% |
| ADMA Biologics, Inc. | 5.12 Million USD | 5143.789% |
| Clene Inc. | -43.24 Million USD | -497.216% |
| Capricor Therapeutics, Inc. | -23 Million USD | -1022.353% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | -432.71% |
| GeoVax Labs, Inc. | -26.66 Million USD | -868.331% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | 13.795% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | -603.094% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | 1195.499% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | 5359.238% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | -695.031% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | -63.027% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 62.262% |
| Evaxion Biotech A/S | -21.4 Million USD | -1106.569% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | -288.831% |
| Verve Therapeutics, Inc. | -217.66 Million USD | -18.64% |
| Trevena, Inc. | -35.28 Million USD | -631.813% |
| Surrozen, Inc. | -41.13 Million USD | -527.852% |
| Tyra Biosciences, Inc. | -79.59 Million USD | -224.457% |
| Cingulate Inc. | -22.95 Million USD | -1025.138% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | -3361.225% |
| Unity Biotechnology, Inc. | -37.28 Million USD | -592.653% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | -3039.197% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | -152.52% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | -280.736% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | -342.407% |
| Clearmind Medicine Inc. | -8.71 Million USD | -2864.665% |
| Kronos Bio, Inc. | -121.83 Million USD | -111.969% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | -247.37% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -10477.559% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -156.124% |
| Statera Biopharma, Inc. | 38.93 Million USD | 763.265% |
| ImmunityBio, Inc. | -436.18 Million USD | 40.795% |
| Korro Bio, Inc. | -80.9 Million USD | -219.196% |
| Kineta, Inc. | -15.71 Million USD | -1543.388% |
| BioVie Inc. | -31.95 Million USD | -708.264% |
| Codexis, Inc. | -49.28 Million USD | -423.998% |
| Celularity Inc. | -183.94 Million USD | -40.39% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | -16.583% |
| Celcuity Inc. | -58.3 Million USD | -342.878% |
| Virax Biolabs Group Limited | -6.6 Million USD | -3807.344% |
| Cibus, Inc. | -314.58 Million USD | 17.91% |
| Eledon Pharmaceuticals, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | -665.547% |
| IN8bio, Inc. | -28.5 Million USD | -805.985% |
| Kodiak Sciences Inc. | -259.02 Million USD | 0.302% |
| Annexon, Inc. | -141.57 Million USD | -82.406% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | -129.347% |
| Assembly Biosciences, Inc. | -64.19 Million USD | -302.271% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | -823.777% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | -12.274% |
| Eyenovia, Inc. | -24.1 Million USD | -971.275% |
| Puma Biotechnology, Inc. | 44.78 Million USD | 676.639% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -79604.321% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | -249.902% |
| Arcellx, Inc. | -64.14 Million USD | -302.591% |
| Cardiff Oncology, Inc. | -45.01 Million USD | -473.693% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | -109.143% |
| Regulus Therapeutics Inc. | -30.88 Million USD | -736.222% |
| Moolec Science SA | -52.07 Million USD | -395.899% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | -400.411% |
| Geron Corporation | -174.78 Million USD | -47.751% |
| LAVA Therapeutics N.V. | -40.41 Million USD | -538.944% |
| Royalty Pharma plc | 1.88 Billion USD | 113.683% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | -115.934% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -2669.573% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | -1145.095% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | -55.493% |
| Humacyte, Inc. | -96.45 Million USD | -167.725% |
| Structure Therapeutics Inc. | -102.45 Million USD | -152.044% |
| 89bio, Inc. | -134.46 Million USD | -92.054% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | -227.407% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | 6473.198% |
| Genelux Corporation | -24.16 Million USD | -968.661% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | -664.03% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | -57.981% |
| Notable Labs, Ltd. | -14.4 Million USD | -1693.347% |
| Liquidia Corporation | -70.05 Million USD | -268.649% |
| Mustang Bio, Inc. | -48.06 Million USD | -437.299% |
| Immunovant, Inc. | -269.97 Million USD | 4.347% |
| Quantum-Si incorporated | -91.8 Million USD | -181.297% |
| Arbutus Biopharma Corporation | -70.98 Million USD | -263.793% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | -1237.487% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -153.149% |
| Acasti Pharma Inc. | -11.3 Million USD | -2185.125% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | -1060.469% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -1584.454% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | -22.673% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | -5947.336% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -1526.209% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | -797.421% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | -597.386% |
| PepGen Inc. | -83.58 Million USD | -208.968% |
| Moleculin Biotech, Inc. | -29.5 Million USD | -775.278% |
| United Therapeutics Corporation | 1.38 Billion USD | 118.621% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -1027.842% |
| Solid Biosciences Inc. | -93.43 Million USD | -176.39% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | -5311.909% |
| Immuneering Corporation | -58.06 Million USD | -344.779% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 8052547.771% |
| Silo Pharma, Inc. | -3.62 Million USD | -7021.532% |
| Belite Bio, Inc | -31.52 Million USD | -719.062% |
| XOMA Corporation | -39.36 Million USD | -556.069% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | -282.881% |
| Bionomics Limited | -9.83 Million USD | -2525.212% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -207.486% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -646.235% |
| uniQure N.V. | -253.1 Million USD | -2.032% |
| Cassava Sciences, Inc. | -95.68 Million USD | -169.882% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -3432.675% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -99.409% |
| Forte Biosciences, Inc. | -32.47 Million USD | -695.154% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | -3107.787% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | -815.135% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -79604.321% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -2217.943% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | -1524.061% |
| Altimmune, Inc. | -87.93 Million USD | -193.674% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | -180.457% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -646.235% |
| Compugen Ltd. | -12.51 Million USD | -1963.295% |
| Peak Bio, Inc. | -1356.23 USD | -19041065.584% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | -431.384% |
| Benitec Biopharma Inc. | -22.49 Million USD | -1048.253% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -6.578% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | -804.747% |
| Zura Bio Limited | -60.56 Million USD | -326.402% |
| PolyPid Ltd. | -20.26 Million USD | -1174.451% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | -1554.019% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | -804.747% |
| Instil Bio, Inc. | -146.12 Million USD | -76.73% |
| argenx SE | -216.02 Million USD | -19.544% |
| Immunome, Inc. | -28.27 Million USD | -813.452% |
| Compass Therapeutics, Inc. | -48.47 Million USD | -432.754% |
| Verona Pharma plc | -52.46 Million USD | -392.193% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | -172.488% |
| Shattuck Labs, Inc. | -87.61 Million USD | -194.746% |
| CervoMed Inc. | -2.17 Million USD | -11790.285% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | -111.251% |
| Plus Therapeutics, Inc. | -12.69 Million USD | -1934.523% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -436.061% |
| Moolec Science SA | -52.07 Million USD | -395.899% |
| Enveric Biosciences, Inc. | -17.13 Million USD | -1406.664% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | -98.052% |
| AnaptysBio, Inc. | -143.16 Million USD | -80.382% |
| Design Therapeutics, Inc. | -66.32 Million USD | -289.358% |
| Leap Therapeutics, Inc. | -80.98 Million USD | -218.868% |
| NeurAxis, Inc. | -6.66 Million USD | -3774.892% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | -584.085% |
| Lumos Pharma, Inc. | -36.57 Million USD | -606.158% |
| Achilles Therapeutics plc | -70.44 Million USD | -266.602% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | -172.488% |
| 180 Life Sciences Corp. | -22.13 Million USD | -1066.719% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | 4530.109% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -10477.559% |
| Nutriband Inc. | -5.12 Million USD | -4942.039% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | -135.305% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | -365.872% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | -410.864% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | -295.609% |
| MoonLake Immunotherapeutics | -54.1 Million USD | -377.254% |
| Palisade Bio, Inc. | -12.28 Million USD | -2002.777% |
| Tourmaline Bio, Inc. | -45.37 Million USD | -469.116% |
| Beam Therapeutics Inc. | -156.47 Million USD | -65.039% |
| Neurogene Inc. | -52.28 Million USD | -393.903% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | -89.202% |
| AEON Biopharma, Inc. | -48.36 Million USD | -433.988% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | -177.626% |
| Sesen Bio, Inc. | -50.84 Million USD | -407.95% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | -215.191% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | -1991.024% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | 39.583% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | -145.484% |
| Athira Pharma, Inc. | -116.7 Million USD | -121.281% |
| Vaccinex, Inc. | -19.74 Million USD | -1207.687% |
| HCW Biologics Inc. | -23.57 Million USD | -995.357% |
| XOMA Corporation | -39.36 Million USD | -556.069% |
| Nektar Therapeutics | -243.1 Million USD | -6.226% |
| Arvinas, Inc. | -394.8 Million USD | 34.589% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 136948.855% |
| Merus N.V. | -149.2 Million USD | -73.076% |
| Omega Therapeutics, Inc. | -93.49 Million USD | -176.224% |
| Quince Therapeutics, Inc. | -31.26 Million USD | -726.11% |
| Rezolute, Inc. | -68.42 Million USD | -277.42% |
| Clene Inc. | -43.24 Million USD | -497.216% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -1574.483% |
| BeyondSpring Inc. | -21.54 Million USD | -1098.895% |
| Synlogic, Inc. | -55.16 Million USD | -368.16% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | -2037.234% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | -2326.63% |
| Peak Bio, Inc. | -1356.23 USD | -19041065.584% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | -695.447% |
| Krystal Biotech, Inc. | 17.9 Million USD | 1542.37% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | -118.067% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | 24.346% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | -5506.118% |
| MannKind Corporation | 15.12 Million USD | 1806.934% |
| Ikena Oncology, Inc. | -74.39 Million USD | -247.113% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | -1950.679% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | 1370.438% |
| Gossamer Bio, Inc. | -172.15 Million USD | -50.008% |
| CohBar, Inc. | -12.06 Million USD | -2040.288% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | -912.356% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -760.09% |
| Legend Biotech Corporation | -477.87 Million USD | 45.96% |
| Mural Oncology plc | -192.72 Million USD | -33.999% |
| Biora Therapeutics, Inc. | -114.05 Million USD | -126.421% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -1499.49% |
| Disc Medicine, Inc. | -91.02 Million USD | -183.704% |
| Champions Oncology, Inc. | -5.05 Million USD | -5009.656% |
| REGENXBIO Inc. | -239.46 Million USD | -7.842% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -2309.381% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -363.165% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | -566.117% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | -128.926% |
| Vaxart, Inc. | -74.72 Million USD | -245.599% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | -633.469% |
| Cellectis S.A. | -98.09 Million USD | -163.257% |
| Longeveron Inc. | -20.06 Million USD | -1187.348% |
| Repare Therapeutics Inc. | -114.27 Million USD | -125.987% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | 41.201% |
| Inozyme Pharma, Inc. | -74.81 Million USD | -245.188% |
| Revolution Medicines, Inc. | -430.58 Million USD | 40.025% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | -4006.249% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | -738.748% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -246.215% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | 5367.02% |
| Anixa Biosciences, Inc. | -10.96 Million USD | -2255.148% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 105.608% |
| Denali Therapeutics Inc. | -179.97 Million USD | -43.489% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -271139.812% |
| Veru Inc. | -89.97 Million USD | -187.013% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | -860.793% |
| Cingulate Inc. | -22.95 Million USD | -1025.138% |
| Passage Bio, Inc. | -98.34 Million USD | -162.599% |
| Context Therapeutics Inc. | -25.06 Million USD | -930.471% |
| Exicure, Inc. | -15.53 Million USD | -1561.896% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -25.321% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | -598.404% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | -4231.033% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | -53.292% |
| Nuvalent, Inc. | -149.49 Million USD | -72.746% |
| ABVC BioPharma, Inc. | -8.13 Million USD | -3075.465% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | -200.652% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | -755.729% |
| OmniAb, Inc. | -49.73 Million USD | -419.278% |
| Anew Medical, Inc. | -1.3 Million USD | -19751.942% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | -1988.661% |
| Lipocine Inc. | -16.32 Million USD | -1482.107% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | -287.344% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | -247.553% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -577.21% |
| G1 Therapeutics, Inc. | -39.01 Million USD | -561.921% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | -1064.144% |
| Sage Therapeutics, Inc. | -545.07 Million USD | 52.622% |
| Ocugen, Inc. | -64.82 Million USD | -298.356% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | -178.969% |
| Q32 Bio Inc. | -86.5 Million USD | -198.539% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | -1425.622% |
| Alumis Inc. Common Stock | -156.89 Million USD | -64.601% |
| Equillium, Inc. | -12.13 Million USD | -2027.55% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | -341.651% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -3167.501% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -1269.187% |
| Galera Therapeutics, Inc. | -46.69 Million USD | -453.075% |
| Evelo Biosciences, Inc. | -106.34 Million USD | -142.834% |
| Comera Life Sciences Holdings, Inc. | -17.88 Million USD | -1343.774% |
| Dominari Holdings Inc. | -22.44 Million USD | -1050.811% |
| Edesa Biotech, Inc. | -8.19 Million USD | -3053.083% |
| vTv Therapeutics Inc. | -25.41 Million USD | -916.221% |
| Bio-Techne Corporation | 326.66 Million USD | 179.055% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | 32.9% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | 219.342% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | -96.969% |
| Candel Therapeutics, Inc. | -37.43 Million USD | -589.915% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -70.907% |
| Nkarta, Inc. | -120.48 Million USD | -114.343% |
| BioCardia, Inc. | -11.56 Million USD | -2133.927% |
| Iterum Therapeutics plc | -34.58 Million USD | -646.796% |